Clinical Trials Directory

Trials / Completed

CompletedNCT04950465

A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population

An 8 Week, Randomised, Examiner-blind, Controlled Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
271 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to support long-term dentinal hypersensitivity (DH) relief claims of 0.454 percent (%) stannous fluoride (SnF2) containing toothpastes in China.

Detailed description

This study will be a single centre, randomised, controlled, examiner-blind, 3 treatment arm, parallel group design study, stratified by maximum baseline Schiff sensitivity score (of the 2 selected 'test teeth'), with a treatment period of 8 weeks, to investigate the clinical efficacy of a SnF2 dentifrice in the reduction of DH in a Chinese population. The SnF2 test dentifrice will be compared to commercialised negative and positive control dentifrices. Participants will be instructed to brush teeth with their assigned dentifrice according to the product use instructions provided. DH assessments will be conducted at Baseline, 4 and 8 weeks. Participants will also be requested to complete a short-form version of the Dentine Hypersensitivity Experience Questionnaire (DHEQ-15) at the Baseline and Week 8 Visits.

Conditions

Interventions

TypeNameDescription
OTHERSensodyne Sensitivity & GumSensodyne Sensitivity \& Gum toothpaste containing 0.454% SnF2.
OTHERCrest Cavity Protection Fresh LimeCrest Cavity Protection Fresh Lime is containing 1150 parts per million fluoride as Sodium fluoride.
OTHERSensodyne Repair and ProtectSensodyne Repair and Protect dentifrice containing 5.0% weight/weight calcium sodium phosphosilicate.

Timeline

Start date
2021-07-27
Primary completion
2022-01-25
Completion
2022-01-25
First posted
2021-07-06
Last updated
2023-10-23
Results posted
2023-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04950465. Inclusion in this directory is not an endorsement.